Sudeep Pharma Share Price
1329.30+36.50 (+2.82%)
+71.71% past 1 Year
News
Sudeep Pharma flags steady state asset turns for battery and greenfield facilities
Equity
SUDEEPPHRM
Sudeep Pharma outlines strategy to meet FY27 growth objectives via expansion
Equity
SUDEEPPHRM
Sudeep Pharma sustains 30 percent profit growth outlook post greenfield expansion
Equity
SUDEEPPHRM
Sudeep Pharma greenfield PFN facility expected to commission in Q3
Equity
SUDEEPPHRM
Sudeep Pharma plans major capacity expansion to 200 KTPA by FY30-31
Equity
SUDEEPPHRM
Sudeep Pharma targets Phase 1 commissioning of SAM project by April 2027
Equity
SUDEEPPHRM
Sudeep Pharma outlines gradual recovery plan for NSS overseas subsidiary margins
Equity
SUDEEPPHRM
Sudeep Pharma expects specialty ingredients growth to normalise from Q2 FY27
Equity
SUDEEPPHRM
Sudeep Pharma reiterates EBITDA margin guidance range for overall business
Equity
SUDEEPPHRM
Sudeep Pharma expects Q1 FY27 momentum to continue into Q2
Equity
SUDEEPPHRM
Sudeep Pharma Q1 EBITDA rises year-on-year despite slight margin compression
Equity
SUDEEPPHRM
Sudeep Pharma Q1 revenue rises year-on-year to Rs 158 crores
Equity
SUDEEPPHRM
Sudeep Pharma Q1 consolidated net profit rises sharply year-on-year
Equity
SUDEEPPHRM
Sudeep Pharma informs about press release
Equity
SUDEEPPHRM
Sudeep Pharma - Quaterly Results
Equity
SUDEEPPHRM
Sudeep Pharma plans major FY27 capacity expansion across key segments
Equity
SUDEEPPHRM
Sudeep Pharma reports Profit after tax of 25.76 Crores, in the March 2026 quarter
Equity
SUDEEPPHRM
Sudeep Pharma Q4 EBITDA jumps with strong year-on-year margin expansion
Equity
SUDEEPPHRM
Sudeep Pharma Q4 FY earnings show healthy YoY growth in revenue and PAT
Equity
SUDEEPPHRM
Sudeep Pharma informs about certificate
Equity
SUDEEPPHRM